✦ LIBER ✦

Immunosuppressive treatment for juvenile myasthenia gravis

✍ Scribed by B. Badurska; B. Ryniewicz; H. Strugalska

Publisher: Springer
Year: 1992
Tongue: English
Weight: 260 KB
Volume: 151
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf01954388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Juvenile myasthenia gravis

✍ Laura M. Chiang; Basil T. Darras; Peter B. Kang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Thymectomy for inducing remission in juv

Thymectomy for inducing remission in juvenile myasthenia gravis

✍ Iain A. M. Hennessey; Anna May Long; Imelda Hughes; Gillian Humphrey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 137 KB

Treatment of myasthenia gravis

✍ C. Scoppetta; P. Tonali; A. Evoli; P. David; F. Crucitti; M. L. Vaccario 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 576 KB

In the treatment of myasthenia gravis (MG) considerable progress has recently been achieved. Our experience is based on the observation of 139 patients with an average follow-up of 3 years and 4 months. A treatment plan and results are presented. Indications for thymectomy: all cases of MG in adult

Treatment of myasthenia gravis

✍ David P. Richman 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 204 KB

Prostigmin treatment of myasthenia gravi

Prostigmin treatment of myasthenia gravis

✍ F. M. Miller; Harold H. Dodds 📂 Article 📅 1939 🏛 Springer US 🌐 English ⚖ 341 KB

Immunoglobulin treatment in refractory m

Immunoglobulin treatment in refractory myasthenia gravis

✍ Anat Achiron; Yoram Barak; Shmuel Miron; Ida Sarova-Pinhas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia